Net Present Value Assessment
for a Small Molecule Targeting
Chronic Kidney Disease
Built a dynamic model for patient and market share forecasts in US and EU5. Incorporated impact of competition and unmet medical need
Calculated the overall Net Present Value (NPV) of the asset with a dynamic model with different scenarios/base cases.